Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M126,626Revenue $M34,858Net Margin (%)12.0Z-Score2.3
Enterprise Value $M300,731EPS $1.7Operating Margin %15.6F-Score5
P/E(ttm))28.7Cash Flow Per Share $0Pre-tax Margin (%)12.9Higher ROA y-yN
Price/Book20.110-y EBITDA Growth Rate %0.5Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.45-y EBITDA Growth Rate %-5.1Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %-43.6ROA % (ttm)6.8Higher Current Ratio y-yN
Dividend Yield %5.5Insider Buy (3m)0ROE % (ttm)47.5Less Shares Outstanding y-yY
Payout Ratio %141Shares Outstanding M2,678ROI % (ttm)14.0Gross Margin Increase y-yY

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKDodge & Cox 2014-12-31 Reduce-0.64%$41.3 - $47.14
($44.76)
$ 47.295%Reduce -37.91%23,959,301
GSKHOTCHKIS & WILEY 2014-12-31 Add0.21%$41.3 - $47.14
($44.76)
$ 47.295%Add 13.04%12,213,885
GSKDavid Dreman 2014-12-31 Sold Out -0.01%$41.3 - $47.14
($44.77)
$ 47.295%Sold Out0
GSKDodge & Cox 2014-09-30 Reduce-1.11%$46.29 - $54.52
($49.01)
$ 47.29-4%Reduce -35.93%38,589,161
GSKHOTCHKIS & WILEY 2014-09-30 Add0.98%$46.29 - $54.52
($49.01)
$ 47.29-4%Add 118.31%10,804,564
GSKCharles Brandes 2014-09-30 Add0.56%$46.29 - $54.52
($49.01)
$ 47.29-4%Add 36.63%3,415,717
GSKIrving Kahn 2014-09-30 Buy 0.38%$46.29 - $54.52
($49.01)
$ 47.29-4%New holding51,000
GSKNWQ Managers 2014-09-30 Add0.03%$46.29 - $54.52
($49.01)
$ 47.29-4%Add 39.82%208,125
GSKDavid Dreman 2014-09-30 Buy 0.01%$46.29 - $54.52
($49.01)
$ 47.29-4%New holding1,328
GSKHOTCHKIS & WILEY 2014-06-30 Add0.93%$51.55 - $56.39
($54.16)
$ 47.29-15%Add 13358.60%4,949,118
GSKCharles Brandes 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 47.29-15%Add 15.52%2,500,048
GSKJohn Rogers 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 47.29-15%Add 49.33%988,772
GSKJames Barrow 2014-06-30 Buy 0.02%$51.55 - $56.39
($54.16)
$ 47.29-15%New holding270,900
GSKJohn Rogers 2014-03-31 Add0.16%$50.9 - $56.66
($54.07)
$ 47.29-14%Add 57.21%662,150
GSKVanguard Health Care Fund 2014-03-31 Sold Out -0.11%$50.9 - $56.66
($54)
$ 47.29-14%Sold Out0
GSKNWQ Managers 2014-03-31 Reduce-0.03%$50.9 - $56.66
($54.07)
$ 47.29-14%Reduce -28.91%148,800
GSKHOTCHKIS & WILEY 2014-03-31 Buy 0.01%$50.9 - $56.66
($54.07)
$ 47.29-14%New holding36,773
GSKJohn Rogers 2013-12-31 Add0.19%$49.31 - $53.68
($51.87)
$ 47.29-10%Add 208.93%421,201
GSKCharles Brandes 2013-12-31 Add0.16%$49.31 - $53.68
($51.87)
$ 47.29-10%Add 13.11%2,145,461
GSKVanguard Health Care Fund 2013-12-31 Reduce-0.14%$49.31 - $53.68
($51.87)
$ 47.29-10%Reduce -55.18%644,881
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$22118.32view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14127.2view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29807.94view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12300.25view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14243.07view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12300.25view

Press Releases about GSK :

    Quarterly/Annual Reports about GSK:

      News about GSK:

      Articles On GuruFocus.com
      British Stock Picks From Gurus During Q4 Mar 24 2015 
      Pfizer In The Process Of Making Path Breaking Vaccine Mar 18 2015 
      Bestinfond Adds More Than a Dozen Foreign Stocks to Portfolio Mar 06 2015 
      Causeway International Value Fund Adds 2 New Stocks Mar 03 2015 
      Novartis Gets FTC Nod To Buyout Glaxo Smithkline’s Cancer Drugs Feb 25 2015 
      Dodge & Cox 2014 Equity Year in Review Feb 19 2015 
      Bestinfond's Top 5 New Buys During Q4 Feb 03 2015 
      Can GlaxoSmithKline Continue Striving in the Face of World Challenges? Jan 30 2015 
      Tumor Drug Takes The Focus At OncoMed Pharmaceuticals Jan 29 2015 
      Gilead Sciences Still has More Upside Jan 22 2015 

      More From Our Partners
      Tekmira Up on Ebola Candidate Update from the FDA - Analyst Blog Apr 13 2015 - ZACKS

      More From Other Websites
      Glaxo to Change its Compensation Program for U.S. Sales Reps Apr 13 2015
      Tekmira Up on Ebola Candidate Update from the FDA - Analyst Blog Apr 13 2015
      Should The FDA Require CV Outcome Studies For Diabetes Drugs Before Approval? Apr 13 2015
      3 Great Growth Stocks For Savvy Investors: GlaxoSmithKline plc, Legal & General Group Plc And Sports... Apr 13 2015
      Why AstraZeneca plc Beats GlaxoSmithKline plc Apr 10 2015
      GlaxoSmithKline plc vs Shire PLC: Which Pharma Stock Is The Better Buy? Apr 08 2015
      Shell’s BG Buy Trumps GlaxoSmithKline as Biggest U.K.-Only Deal Apr 08 2015
      Why I’d Buy Tesco PLC, Hold GlaxoSmithKline plc & Dump Diageo PLC Apr 07 2015
      Workplace wellness has a long way to go Apr 06 2015
      On The Lookout For Delicious Dividends? Search No Further Than GlaxoSmithKline plc, Imperial Tobacco... Apr 06 2015
      Why GlaxoSmithKline plc Beats AstraZeneca plc And Royal Dutch Shell Plc Beats BP plc For Your... Apr 04 2015
      Q&A: How GSK/Salix layoffs will impact the Triangle Apr 03 2015
      GlaxoSmithKline to move 150 Cambridge vaccine research jobs out of state Apr 03 2015
      Pfizer halts China vaccine sales after import license not renewed Apr 03 2015
      GlaxoSmithKline to open global R&D center in Rockville Apr 02 2015
      GSK to establish global vaccines R&D centre in the US Apr 02 2015
      Your Instant 4-Share ISA: Standard Life Plc, BTG plc, Berkeley Group Holdings PLC And Antofagasta... Apr 02 2015
      Pfizer Says Ceasing Vaccine Commercial Operations in China Apr 01 2015
      EWU Fell 1.69% despite Positive Economic Growth in the UK Apr 01 2015
      Why Is Pfizer’s Revenue Stream Declining? Apr 01 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK